These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32031639)

  • 21. Resistance development in
    Bösch A; Macha ME; Ren Q; Kohler P; Qi W; Babouee Flury B
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0162522. PubMed ID: 37882542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
    Pasquali F; Manfreda G
    Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Determinants of Resistance to Extended-Spectrum Cephalosporin and Fluoroquinolone in Escherichia coli Isolated from Diseased Pigs in the United States.
    Hayer SS; Lim S; Hong S; Elnekave E; Johnson T; Rovira A; Vannucci F; Clayton JB; Perez A; Alvarez J
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33115839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China.
    Xia LN; Li L; Wu CM; Liu YQ; Tao XQ; Dai L; Qi YH; Lu LM; Shen JZ
    Foodborne Pathog Dis; 2010 Feb; 7(2):207-15. PubMed ID: 19911944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the efflux pump QepA2 combined with chromosomally mediated mechanisms on quinolone resistance and bacterial fitness in Escherichia coli.
    Machuca J; Briales A; Díaz-de-Alba P; Martínez-Martínez L; Pascual Á; Rodríguez-Martínez JM
    J Antimicrob Chemother; 2015 Sep; 70(9):2524-7. PubMed ID: 26041043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
    Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
    Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates.
    Liu X; Lazzaroni C; Aly SA; Thungrat K; Boothe DM
    Vet Microbiol; 2014 Dec; 174(3-4):514-522. PubMed ID: 25465666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmid-mediated fluoroquinolone resistance associated with extra-intestinal
    Shetty SS; Deekshit VK; Jazeela K; Vittal R; Rohit A; Chakraborty A; Karunasagar I
    Indian J Med Res; 2019 Feb; 149(2):192-198. PubMed ID: 31219083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype-by-environment interactions due to antibiotic resistance and adaptation in Escherichia coli.
    Hall AR
    J Evol Biol; 2013 Aug; 26(8):1655-64. PubMed ID: 23701170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
    Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
    Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptation Through Lifestyle Switching Sculpts the Fitness Landscape of Evolving Populations: Implications for the Selection of Drug-Resistant Bacteria at Low Drug Pressures.
    Matange N; Hegde S; Bodkhe S
    Genetics; 2019 Mar; 211(3):1029-1044. PubMed ID: 30670539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Population Bottleneck Size and Selective Regime on Genetic Diversity and Evolvability in Bacteria.
    Wein T; Dagan T
    Genome Biol Evol; 2019 Nov; 11(11):3283-3290. PubMed ID: 31688900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide transcriptome analysis of fluoroquinolone resistance in clinical isolates of Escherichia coli.
    Yamane T; Enokida H; Hayami H; Kawahara M; Nakagawa M
    Int J Urol; 2012 Apr; 19(4):360-8. PubMed ID: 22211478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conjugal transfer of PMQR from uropathogenic E.coli under high ciprofloxacin selection pressure generates gyrA mutation.
    Basu S; Mukherjee M
    Microb Pathog; 2019 Jul; 132():26-29. PubMed ID: 30999022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
    Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
    J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations.
    Drago L; Nicola L; Mattina R; De Vecchi E
    BMC Microbiol; 2010 Apr; 10():119. PubMed ID: 20409341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential Acquisition of Virulence and Fluoroquinolone Resistance Has Shaped the Evolution of Escherichia coli ST131.
    Ben Zakour NL; Alsheikh-Hussain AS; Ashcroft MM; Khanh Nhu NT; Roberts LW; Stanton-Cook M; Schembri MA; Beatson SA
    mBio; 2016 Apr; 7(2):e00347-16. PubMed ID: 27118589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli.
    Martín-Gutiérrez G; Rodríguez-Beltrán J; Rodríguez-Martínez JM; Costas C; Aznar J; Pascual Á; Blázquez J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4252-8. PubMed ID: 27139482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic trajectories to fluoroquinolone resistance in Francisella tularensis subsp. holarctica live vaccine strain.
    Sutera V; Hennebique A; Lopez F; Fernandez N; Schneider D; Maurin M
    Int J Antimicrob Agents; 2020 Dec; 56(6):106153. PubMed ID: 32911069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
    Chenia HY; Pillay B; Pillay D
    J Antimicrob Chemother; 2006 Dec; 58(6):1274-8. PubMed ID: 17040923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.